Progress in breast cancer screening over the past 50 years: A remarkable story, but still work to doFebruary 19, 2023Breast Cancer
Oncology PracticeOmit radiation in older women with low-risk, ER+ breast cancerFebruary 17, 2023Breast CancerPatient & Survivor Care
Oncology PracticeBreast cancer exacts high financial toll worldwideFebruary 16, 2023Breast CancerPractice ManagementBusiness of Medicine
Oncology PracticeGenomic clues to poor outcomes in young breast cancer patientsFebruary 15, 2023Breast Cancer
Oncology Practice‘Valid option’ for partial breast irradiation in breast cancerFebruary 10, 2023Breast Cancer
Oncology PracticeRadiotherapy for early breast cancer: Sharp cutoff at age 70February 10, 2023Breast Cancer
Oncology PracticeUse of diagnostic mammograms is inconsistent, survey findsFebruary 7, 2023Metastatic Breast CancerBreast Cancer
Oncology PracticeFDA OKs sacituzumab govitecan for HR+ metastatic breast cancerFebruary 6, 2023Breast Cancer
Oncology PracticeRace and geography tied to breast cancer care delaysFebruary 6, 2023Breast CancerDiversity in MedicinePatient & Survivor Care
Oncology PracticeQuality of life predicts chemo tolerance in early breast cancerFebruary 3, 2023Breast CancerPatient & Survivor Care
Oncology PracticeFDA OKs elacestrant for ESR1+ advanced, metastatic breast cancerFebruary 2, 2023Metastatic Breast CancerBreast Cancer
Oncology PracticeDisparities in breast cancer deaths, MRI screening persistJanuary 30, 2023Breast CancerBusiness of Medicine
Commentary: HER2+-targeted therapy, ovarian suppression, and adjuvant therapy in breast cancer, February 2023January 27, 2023Breast Cancer
BC with metabolic abnormalities: No benefit of adding metformin to neoadjuvant chemotherapyJanuary 26, 2023Breast Cancer
